Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” fourth quarter 2024 investor letter ...

Danaher Corporation DHR has failed to impress investors with its recent operational performance due to weakness across its ...

We recently published a list of Why These 15 Big-Cap Stocks Are Plunging So Far in 2025. In this article, we are going to ...

As previously reported, Stifel analyst Daniel Arias upgraded Danaher (DHR) to Buy from Hold with an unchanged price target of $260, telling ...

Shares of Danaher Corp. DHR slid 1.28% to $212.07 Friday, on what proved to be an all-around positive trading session for the ...

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...

Dan Loeb's Third Point 13F reveals portfolio shifts, new stakes, and top holdings. Portfolio value slightly increased to ...

Shares of Danaher Corp. DHR slipped 3.23% to $205.23 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614.56 and Dow ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other big-cap stocks that are plunging so far in 2025. The market has been reversing its gains ...